Axel P. Linke
Advanced in Heart Failure with Preserved Ejection Fraction (HFpEF)

Axel P. Linke

Dresden, SN, DE 
Clinical Trials:Currently Recruiting for 1 Trial
Advanced in Heart Failure with Preserved Ejection Fraction (HFpEF)
Dresden, SN, DE 
OverviewLocationsClinical Research

Overview

Axel Linke practices in Dresden, Germany. Mr. Linke is rated as an Advanced expert by MediFind in the treatment of Heart Failure with Preserved Ejection Fraction (HFpEF). His top areas of expertise are Aortic Valve Stenosis, Aortic Regurgitation, Cardiogenic Shock, Transcatheter Aortic Valve Replacement (TAVR), and Aortic Valve Replacement.

His clinical research consists of co-authoring 348 peer reviewed articles and participating in 14 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 28 articles in the study of Heart Failure with Preserved Ejection Fraction (HFpEF).

Gender
Male

Locations

Dresden, SN, Germany
Other Locations
Duesseldorf, NW, Germany
BG University Hospital Bergmannsheil, Frankfurt Am Main, HE, Germany
University Heart And Vascular Center Hamburg And Asklepios Clinic St. Georg, Winnenden And Zentralklinik Bad Berka, Bad Berka, TH, Germany
Leipzig, SN, Germany
Cardiovascular Institute At Mount Sinai School Of Medicine, Switzerland . Mount Sinai School Of Medicine, Berlin, BE, Germany
Bonn, NW, Germany
Kiel, SH, Germany
Herzzentrum Ludwigshafen
Ludwigshafen Am Rhein, RP, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

14 Clinical Trials

Transcatheter Repair of Mitral Regurgitation With Edwards PASCAL Transcatheter Valve Repair System: A European Prospective, Multicenter Post Market Clinical Follow-Up (PMCF)
Transcatheter Repair of Mitral Regurgitation With Edwards PASCAL Transcatheter Valve Repair System: A European Prospective, Multicenter Post Market Clinical Follow-Up (PMCF)
Enrollment Status: Recruiting
Publish Date: June 26, 2025
Intervention Type: Device
Edwards EVOQUE Transcatheter Tricuspid Valve Replacement: Pivotal Clinical Investigation of Safety and Clinical Efficacy Using a Novel Device
Edwards EVOQUE Transcatheter Tricuspid Valve Replacement: Pivotal Clinical Investigation of Safety and Clinical Efficacy Using a Novel Device
Enrollment Status: Active_not_recruiting
Publish Date: October 09, 2025
Intervention Type: Device, Drug
Study Phase: Not Applicable
Expanded Clinical Study of the Tendyne Mitral Valve System
Expanded Clinical Study of the Tendyne Mitral Valve System
Enrollment Status: Completed
Publish Date: July 17, 2025
Intervention Type: Device
Study Phase: Not Applicable
A Post-Market Study Assessment of the Safety and Performance of the MitraClip G4 System
A Post-Market Study Assessment of the Safety and Performance of the MitraClip G4 System
Enrollment Status: Active_not_recruiting
Publish Date: July 11, 2025
Intervention Type: Device
Assessment of the St Jude Medical Portico Resheathable Aortic Valve System-Alternative Access
Assessment of the St Jude Medical Portico Resheathable Aortic Valve System-Alternative Access
Enrollment Status: Completed
Publish Date: February 11, 2025
Intervention Type: Device
Study Phase: Not Applicable
REDUCER-I: An Observational Study of the Neovasc Reducer™ System
REDUCER-I: An Observational Study of the Neovasc Reducer™ System
Enrollment Status: Active_not_recruiting
Publish Date: January 01, 2025
Intervention Type: Device
CONtrolled Delivery For ImproveD outcomEs With cliNiCal Evidence
CONtrolled Delivery For ImproveD outcomEs With cliNiCal Evidence
Enrollment Status: Completed
Publish Date: October 21, 2024
Intervention Type: Device
Study Phase: Not Applicable
Randomized, Multi-Center, Event-Driven Trial of TAVI Versus SAVR in Patients With Symptomatic Severe Aortic Valve Stenosis and Intermediate Risk of Mortality, as Assessed by STS-Score - DEDICATE
Randomized, Multi-Center, Event-Driven Trial of TAVI Versus SAVR in Patients With Symptomatic Severe Aortic Valve Stenosis and Intermediate Risk of Mortality, as Assessed by STS-Score - DEDICATE
Enrollment Status: Active_not_recruiting
Publish Date: April 26, 2024
Intervention Type: Device, Procedure
Study Phase: Not Applicable
Transcatheter Repair of Tricuspid Regurgitation With Cardioband TR System Post-Market Clinical Follow-Up Study (TriBAND): A European Prospective, Multicenter Post-market Clinical Follow-up Study to Assess Transcatheter Tricuspid Valve Repair With Edwards Cardioband TR System in Patients With Symptomatic Chronic Functional Tricuspid Regurgitation.
Transcatheter Repair of Tricuspid Regurgitation With Cardioband TR System Post-Market Clinical Follow-Up Study (TriBAND): A European Prospective, Multicenter Post-market Clinical Follow-up Study to Assess Transcatheter Tricuspid Valve Repair With Edwards Cardioband TR System in Patients With Symptomatic Chronic Functional Tricuspid Regurgitation.
Enrollment Status: Active_not_recruiting
Publish Date: April 06, 2023
Intervention Type: Device
PROTECTED TAVR: Stroke PROTECTion With SEntinel During Transcatheter
PROTECTED TAVR: Stroke PROTECTion With SEntinel During Transcatheter
Enrollment Status: Completed
Publish Date: February 02, 2023
Intervention Type: Device
Study Phase: Not Applicable
Implantable Cardiac Monitors in High-risk Post-infarction Patients With Cardiac Autonomic Dysfunction and Moderately Reduced Left Ventricular Ejection Fraction
Implantable Cardiac Monitors in High-risk Post-infarction Patients With Cardiac Autonomic Dysfunction and Moderately Reduced Left Ventricular Ejection Fraction
Enrollment Status: Completed
Publish Date: June 23, 2021
Intervention Type: Device
Study Phase: Not Applicable
A Randomized Evaluation of the TriGuard Embolic Deflection Device to Reduce the Impact of Cerebral Embolic Lesions After Transcatheter Aortic Valve Implantation
A Randomized Evaluation of the TriGuard Embolic Deflection Device to Reduce the Impact of Cerebral Embolic Lesions After Transcatheter Aortic Valve Implantation
Enrollment Status: Completed
Publish Date: February 18, 2021
Intervention Type: Procedure, Device
Study Phase: Not Applicable
The RELIEF Trial: REduction or eLimination of mItral rEgurgitation in Degenerative or Functional Mitral Regurgitation With the CardiAQ-Edwards™ Transcatheter Mitral Valve
The RELIEF Trial: REduction or eLimination of mItral rEgurgitation in Degenerative or Functional Mitral Regurgitation With the CardiAQ-Edwards™ Transcatheter Mitral Valve
Enrollment Status: Withdrawn
Publish Date: January 09, 2018
Intervention Type: Device
Study Phase: Phase 1/Phase 2
Evaluation of the BARD® True™ Flow Valvuloplasty Perfusion Catheter for Aortic Valve Dilatation
Evaluation of the BARD® True™ Flow Valvuloplasty Perfusion Catheter for Aortic Valve Dilatation
Enrollment Status: Completed
Publish Date: January 10, 2017
Intervention Type: Device
View 13 Less Clinical Trials

348 Total Publications

Long-Term Outcomes of the DanGer Shock Trial.
Long-Term Outcomes of the DanGer Shock Trial.
Journal: The New England journal of medicine
Published: September 01, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Linke's expertise for a condition
ConditionClose
    View All 10 Advanced Conditions
    View All 31 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile